The deal will allow Greenbutts to produce sample products and pursue FDA approval.Read More
Tags :22nd Century Group
NCSU licensing agreement provides more modes of producing low nicotine plants. Read More
James A. Mish brings extensive global executive leadership experience in science-driven organizations with a recent focus on active pharmaceutical ingredients.Read More
22nd Century Group, a plant biotechnology company and leader in tobacco harm reduction, has announced that it will open specialized laboratories in western New York, USA, dedicated to new scientific research at substantially lower costs Read More
22nd Century Group, a leader in tobacco harm reduction, announced Nov. 9 that the company and its former CEO and founder, Joseph Pandolfino, have settled all litigation and disputes between the parties. “As the founder of 22Read More
22nd Century Group, a leader in tobacco harm reduction, has entered into a new cannabis research collaboration with Anandia Laboratories. As a part of this research collaboration, Vancouver, Canada-based Anandia Laboratories will develop and grow Read More
The New England Journal of Medicine (NEJM) has published an article detailing a landmark study that used low-nicotine Spectrum cigarettes produced by 22nd Century, a leader in tobacco harm reduction. The double-blind, parallel, randomized clinical Read More
22nd Century Group, a leader in tobacco harm reduction, has appointed Gregg M. Gellman as the company’s director of business development and regulatory affairs. Gellman, who was hired for his experience in achieving U.Read More
